http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad6f4526bab8ea4b80a2a0dc48c788cb
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Pio |
| name | Ruben Pio |
| given-name | Ruben |
| organization-name | Health Research Institute of Navarra (IDISNA) Pamplona Spain; Program in Solid Tumors and Biomarkers Center for Applied Medical Research (CIMA) Pamplona Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Spain Authors' Affiliations: 1Division of Oncology, Center for Applied Medical Research (CIMA); Departments of 2Histology and Pathology and 3Biochemistry and Genetics, Schools of Science and Medicine, University of Navarra, Pamplona; and 4CEIT and TECNUN, University of Navarra, San Sebastian, Spain; Authors' Affiliations: 1Division of Oncology, Center for Applied Medical Research (CIMA); Departments of 2Histology and Pathology and 3Biochemistry and Genetics, Schools of Science and Medicine, University of Navarra, Pamplona; and 4CEIT and TECNUN, University of Navarra, San Sebastian, Spain Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Health Research Institute (IDISNA), University of Navarra, Pamplona, Spain; Department of Biochemistry and Genetics, School of Science, University of Navarra, Pamplona, Spain 1University of Navarra, Center for Applied Medical Research (CIMA), Program in Solid Tumors and Biomarkers, Pamplona, Spain.; 2Navarra's Health Research Institute (IdiSNA), Pamplona, Spain.; 3Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; 4University of Navarra, School of Sciences, Department of Biochemistry and Genetics, Pamplona, Spain. *Division of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona 31008, Spain;; §Department of Biochemistry, School of Sciences, University of Navarra, Pamplona 31008, Spain; and Navarra Institute for Health Research (IDISNA) Pamplona Spain; Program of Solid Tumors and Biomarkers CIMA Pamplona Spain; Deparment of Biochemistry and Genetics School of Sciences University of Navarra Pamplona Spain Program in Solid Tumors and Biomarkers, Center for Applied Medical Research; Department of Biochemistry and Genetics, Universidad de Navarra, Pamplona, Spain d Department of Biochemistry and Division of Oncology, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain Center for Applied Medical Research, Program in Solid Tumors and Biomarkers, Pamplona, Spain; IdiSNA (Navarra Institute for Health Research), Pamplona, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Spain; Department of Biochemistry and Genetics, School of Sciences, and Program in Solid Tumors CIMA‐University of Navarre‐IdISNA Pamplona Spain; CIBERONC Centro de Investigación Biomédica en Red de Cáncer Madrid Spain; Department of Biochemistry and Genetics, School of Sciences University of Navarra‐IdISNA Pamplona Spain Program in Solid Tumors, CIMA-University of Navarra, 31008 Pamplona, Spain; Consorcio de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain; Navarra Health Research Institute (IDISNA), 31008 Pamplona, Spain; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, 31009 Pamplona, Spain Division of Oncology, Center for Applied Medical Research, Pamplona, Spain; Department of Biochemistry, School of Sciences, University of Navarra, Calle de Irunlarrea, 1, 31080, Pamplona, Spain Health Research Institute of Navarra (IDISNA) Pamplona Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain; Program in Solid Tumors Center for Applied Medical Research (CIMA) Pamplona Spain IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Navarra, Spain Authors' Affiliations: 1Oncology Division, Center for Applied Medical Research, Departments of 2Pathology, 3Oncology, and 4Thoracic Surgery, Clínica Universidad de Navarra, and Departments of 5Histology and Pathology and 6Biochemistry, Schools of Medicine and Sciences, University of Navarra, Pamplona, Spain; Authors' Affiliations: 1Oncology Division, Center for Applied Medical Research, Departments of 2Pathology, 3Oncology, and 4Thoracic Surgery, Clínica Universidad de Navarra, and Departments of 5Histology and Pathology and 6Biochemistry, Schools of Medicine and Sciences, University of Navarra, Pamplona, Spain Authors' Affiliations: Departments of 1Oncology, 2Pathology, and 3Thoracic Surgery, Clínica Universidad de Navarra; 4Division of Oncology, Center for Applied Medical Research (CIMA), Pamplona, Spain; Departments of 5Thoracic/Head and Neck Medical Oncology and 6Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas María J. Pajares, Jackeline Agorreta, Marta Larrayoz, Teresa Ezponda, Isabel Zudaire, Wenceslao Torre, María D. Lozano, Ruben Pio, and Luis M. Montuenga, Center for Applied Medical Research (CIMA) and Clinica Universidad de Navarra (CUN), University of Navarra, Pamplona, Spain; Aurélien Vesin, Elisabeth Brambilla, Christian Brambilla, and Jean-Francois Timsit, Institut Albert Bonniot, Centre Hospitalier Universitaire Albert Michallon, Institut National de la Santé et de la Recherche Médicale (INSERM)... Division of Oncology Center for Applied Medical Research (CIMA) University of Navarra Pamplona Spain; Department of Biochemistry School of Medicine University of Navarra Pamplona Spain Authors' Affiliations: 1Division of Oncology, Center for Applied Medical Research; 2Department of Biochemistry, School of Sciences, University of Navarra; 3Department of Pulmonary Medicine, School of Medicine, Clinica Universidad de Navarra; 4Department of Histology and Pathology, School of Medicine, University of Navarra; 5Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain; 6Medizinische Klinik m.S. Infektologie und Pulmologie (Arbeitsbereich Pneumologische Onkologie) CCM, Charité-Universitätsmedizin Berlin, Germany; and 7Medical Oncology Department, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain; Authors' Affiliations: 1Division of Oncology, Center for Applied Medical Research; 2Department of Biochemistry, School of Sciences, University of Navarra; 3Department of Pulmonary Medicine, School of Medicine, Clinica Universidad de Navarra; 4Department of Histology and Pathology, School of Medicine, University of Navarra; 5Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain; 6Medizinische Klinik m.S. Infektologie und Pulmologie (Arbeitsbereich Pneumologische Onkologie) CCM, Charité-Universitätsmedizin Berlin, Germany; and 7Medical Oncology Department, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain 4IDISNA and Program in Solid Tumors and Biomarkers, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; 7Department of Biochemistry and Genetics, School of Science, University of Navarra, Pamplona, Spain. Program in Solid Tumors, Center for Applied Medical Research (CIMA), CIBERONC, and Navarra’s Health Research Institute (IDISNA), Pamplona, Spain; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain 1Oncology Division, Center for Applied Medical Research; Departments of; 8Biochemistry, Schools of Medicine and Sciences, University of Navarra, Pamplona, Spain 1Division of Oncology, Center for Applied Medical Research, Pamplona, Spain;; 2Departments of Biochemistry and Oncology Division (CIMA), and Department of Biochemistry and Genetics (School of Science), University of Navarra, Pamplona, Spain, rpio@unav.es. Oncology Division, Center for Applied Medical Research (CIMA), University of Navarra, Avda. Pio XII, 55, Pamplona, 31008, Spain. Fax: +34 948 194714; Tel: +34 948 194700 ext. 1000 Program in Solid Tumors, Center for Applied Medical Research, Pamplona, Spain; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Navarra Health Research Institute, Pamplona, Spain Program in Solid Tumors Center for Applied Medical Research (CIMA) Pamplona Spain; Oncology Division Navarra's Health Research Institute (IDISNA) Pamplona Spain; Department of Biochemistry and Genetics, School of Sciences University of Navarra Pamplona Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain 1Division of Oncology and Departments of; 2Biochemistry, *Division of Oncology, Center for Applied Medical Research,; ‡Department of Biochemistry, School of Medicine, University of Navarra, Pamplona, Spain Department of Cell and Cancer Biology (A.M., L.M.M., R.P., F.C.), National Cancer Institute, NIH, Bethesda, Maryland 20892 Program in Solid Tumours, CIMA Pamplona Spain; Department of Biochemistry and Genetics, School of Sciences University of Navarra Pamplona Spain; Navarra Health Research Institute (IDISNA) Pamplona Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain Authors' Affiliations: 1Oncology Division, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona; 2Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain; 3Nuffield Department of Clinical Laboratory Sciences; 4Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital; 5Department of Medical Oncology, University of Oxford, The Churchill Hospital, Oxford, United Kingdom; 6Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Jinan, China; and 7Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Division of Oncology Center for Applied Medical Research Pamplona Spain; Department of Biochemistry and Genetics School of Sciences University of Navarra Pamplona Spain |
Incoming Links
Total number of triples: 122.